首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1593468

切片检查设备市场规模、份额、成长分析、按产品、按引导技术、按应用、按最终用途、按地区：2024-2031 年行业预测

Biopsy Devices Market Size, Share, Growth Analysis, By Product, By Guidance Technique, By Application, By End Use, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月13日 | 出版商:

SkyQuest | 英文 193 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年切片检查设备的全球市场规模为57.9亿美元，从2023年的66亿美元成长到2031年的188.3亿美元，在预测期间（2024-2031）预计复合年增长率为14.00。

由于癌症（尤其是乳腺癌、前列腺癌和肺癌）发病率的上升以及切片检查技术的进步，切片检查市场正在经历显着增长。这种手术技术对于乳糜泻和恶性等疾病的诊断至关重要，主要由放射科医生、外科医生和介入性心臟病专家使用针对不同器官量身定制的专用仪器进行。电脑断层扫描、MRI 和超音波等影像技术的创新提高了切片检查的精确度和微创性，从而导致了 3D 光学活检和 MRI 标靶切片检查等更复杂方法的采用。这些工具的整合正在促进更有效的器官切片检查，特别是肝臟、肾臟和肺臟。人们对慢性病检测的认识不断提高，也促进了立体定位引导切片检查等先进技术的兴起。然而，它面临着切片检查设备高成本以及新兴地区缺乏合格医疗专业人员等挑战，这可能会阻碍市场的进一步扩张。总体而言，随着医疗保健专业人员在癌症和其他慢性疾病负担日益增加的情况下寻求提高诊断准确性和改善患者治疗结果，不断发展的切片检查技术领域提供了巨大的成长机会。

市场概况
液态生物检体仪器
针切片检查仪器
- 核心切片检查装置
- 核心切片穿刺针
- 核心切片检查枪
- 抽吸切片穿刺针
- 真空切片检查装置
- 真空切片检查系统
- 真空辅助切片穿刺针
治疗托盘
定位线
切片检查台
切片检查钳
- 普通切片检查钳
- 热切片检查钳
其他产品

切片检查设备市场：依导引技术划分

市场概况
非影像引导切片检查
影像引导切片检查
- 超音波切片检查
- 立体定位切片检查
- MRI导引切片检查
- 其他影像引导切片检查技术

切片检查设备市场：依应用分类

市场概况
肺癌
乳癌
大肠直肠癌
肾癌
摄护腺癌
切片检查
其他用途

切片检查设备市场：依最终用户分类

市场概况
医院和乳癌护理中心
影像诊断中心
学术研究所
其他最终用户

切片检查设备市场：按地区

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Becton, Dickinson and Company（US）
Danaher Corporation（US）
B. Braun Melsungen AG（Germany）
Cardinal Health, Inc.（US）
Hologic, Inc.（US）
Olympus Corporation（Japan）
Boston Scientific Corporation（US）
Fujifilm Corporation（Japan）
Medtronic Plc（Ireland）
Stryker Corporation（US）
Cook Group Incorporated（US）
Argon Medical Devices（US）
Inrad, Inc.（US）
Conmed Corporation（US）
Teleflex Incorporated（US）
Qiagen NV（Netherlands）
Thermo Fisher Scientific, Inc.（US）
Summit Medical LLC（US）
Hill-Rom Holdings, Inc.（US）
Gallini SRL（Italy）
Transmed7, LLC（US）
TSK Laboratory International（Japan）
Merit Medical Systems, Inc.（US）
DR. Japan Co., Ltd.（Japan）
IZI Medical Products（US）
Planmed Oy（Finland）
Advin Health Care（India）
F. Hoffmann-La Roche Ltd.（Switzerland）
Bio-Rad Laboratories, Inc.（US）
Illumina, Inc.（US）

简介目录

Product Code: SQMIG35A2955

Global Biopsy Devices Market size was valued at USD 5.79 billion in 2022 and is poised to grow from USD 6.60 billion in 2023 to USD 18.83 billion by 2031, growing at a CAGR of 14.00% in the forecast period (2024-2031).

The biopsy market is experiencing significant growth driven by a rise in cancer prevalence-particularly in breast, prostate, and lung cancers-and advancements in biopsy technologies. This surgical technique, essential in diagnosing conditions such as coeliac disease and malignancies, is primarily performed by radiologists, surgeons, and interventional cardiologists using specialized instruments tailored to various organs. Innovations in imaging technologies, including CT scans, MRIs, and ultrasound, are enhancing the precision and minimal invasiveness of biopsies, leading to the adoption of more sophisticated methods like 3D optical and MRI-targeted biopsies. The integration of these tools is facilitating more efficient organ biopsies, particularly for the liver, kidneys, and lungs. Increasing awareness around chronic disease detection is also contributing to the rise of advanced techniques, such as stereotactic-guided biopsies. However, the market faces challenges, including the high costs associated with biopsy devices and a shortage of qualified healthcare professionals in developing regions, which may impede further market expansion. Overall, the evolving landscape of biopsy technologies presents significant opportunities for growth, as healthcare providers seek to improve diagnostic accuracy and patient outcomes amidst the rising burden of cancer and other chronic diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopsy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopsy Devices Market Segmental Analysis

Global Biopsy Devices Market is segmented on the product, guidance technique, application, end user, and region. By Product, Market is segmented into Liquid Biopsy Instruments, Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Biopsy Tables, Biopsy Forceps, and Other Products. By Guidance Technique, Market for biopsy procedures is segmented into Non-Image-Guided Biopsy and Image-Guided Biopsy techniques. By Application, market is segmented into Lung Cancer, Breast Cancer, Colorectal Cancer, Kidney Cancer, Prostate Cancer, Bone Marrow Biopsy, and Other Applications. By End User, the Market is segmented into Hospitals & Breast Care Centers, Diagnostic Imaging Centers, Academic & Research Institutes, and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Biopsy Devices Market

The global biopsy devices market is notably propelled by the alarming rise in cancer incidence across various demographics and regions. As cancer cases continue to escalate, the demand for accurate and early diagnostic methodologies becomes paramount for effective treatment and management. This heightened awareness of early detection is fostering a significant uptick in biopsy procedures, thus driving innovation and advancements in biopsy technologies. The market is witnessing a surge in the development of sophisticated biopsy devices designed to enhance precision, reduce patient discomfort, and improve diagnostic outcomes, ultimately shaping a robust landscape for future growth in the biopsy devices sector.

Restraints in the Global Biopsy Devices Market

The Global Biopsy Devices market faces a significant restraint in the form of limited access to advanced biopsy technologies, particularly in developing regions. Economic constraints and underdeveloped healthcare infrastructure inhibit the availability and adoption of state-of-the-art biopsy instruments, resulting in a disparity in healthcare quality. This restricted access not only curtails market penetration but also impacts patient outcomes, as many individuals in these regions may remain undiagnosed or receive suboptimal care. Consequently, this gap in accessibility poses a challenge to market expansion and innovation, stifling the potential growth of biopsy device manufacturers looking to enter diverse global markets.

Market Trends of the Global Biopsy Devices Market

The Global Biopsy Devices market is experiencing a significant trend towards the adoption of image-guided biopsy techniques, driven by advancements in imaging technologies such as ultrasound and CT scan guidance. These techniques offer real-time imaging capabilities that enhance the precision and accuracy of biopsy procedures, resulting in improved patient outcomes and diagnostic accuracy. As healthcare providers increasingly prioritize minimally invasive methods and precise interventions, the demand for sophisticated biopsy devices has surged. This growing preference for image-guided approaches is set to propel market growth, reflecting a broader shift towards innovation and technology-driven solutions in the medical field.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Patent Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Technology Analysis
Case Study Analysis
Pricing Analysis

Biopsy Devices Market, By Product

Market Overview
Liquid Biopsy Instruments
Needle-Based Biopsy Instruments
- Core Biopsy Devices
- Core Biopsy Needles
- Core Biopsy Guns
- Aspiration Biopsy Needles
- Vacuum-Assisted Biopsy Devices
- Vacuum-Assisted Biopsy Systems
- Vacuum-Assisted Biopsy Needles
Procedure Trays
Localization Wires
Biopsy Tables
Biopsy Forceps
- General Biopsy Forceps
- Hot Biopsy Forceps
Other Products

Biopsy Devices Market, By Guidance Technique

Market Overview
Non-Image-Guided Biopsy
Image-Guided Biopsy
- Ultrasound-Guided Biopsy
- Stereotactic-Guided Biopsy
- Mri-Guided Biopsy
- Other Image-Guided Biopsy Techniques

Biopsy Devices Market, By Application

Market Overview
Lung Cancer
Breast Cancer
Colorectal Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Other Applications

Biopsy Devices Market, By End User

Market Overview
Hospitals & Breast Care Centers
Diagnostic Imaging Centers
Academic & Research Institutes
Other End Users

Biopsy Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Group Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Argon Medical Devices (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inrad, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conmed Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Summit Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hill-Rom Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gallini S.R.L (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transmed7, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TSK Laboratory International (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DR. Japan Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IZI Medical Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advin Health Care (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments